跳至主要内容
临床试验/ACTRN12622000619741
ACTRN12622000619741招募中未知

The efficacy of adipose-derived stem cells as treatment of hypertrophic scar: a non-randomized controlled trial

Theddeus O. H. Prasetyono0 个研究点目标入组 21 人开始时间: 2022年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • The subject has a hypertrophic scar which has persisted for at least 3 months after the initial wound healed
  • - The hypertrophic scar is of an area of at least 1 x 1 cm2
  • - The hypertrophic scar is at least 5-15 mm in thickness, confirmed with ultrasonography

排除标准

  • - The scar is diagnosed as keloid
  • - The subject has systemic conditions such as diabetes mellitus, hypertension, etc
  • - The subject smoked or consumed alcohol within the last 6 months
  • - The hypertrophic scar received corticosteroid injection therapy within the last month
  • - Subjects have allergies to penicillin, streptomycin, and amphotericin

研究者

发起方
Theddeus O. H. Prasetyono

相似试验